Rohto Pharmaceutical Co., Ltd. operates within the Toilet preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Rohto Pharmaceutical Co., Ltd. with three other
companies in this sector in Japan:
sales of 90.85 billion Japanese Yen [US$817.65 million]
of which 61%
was Cosmetics Business),
Pola Orbis Holdings Incorporation
(218.48 billion Japanese Yen [US$1.97 billion]
(92.21 billion Japanese Yen [US$829.89 million]
of which 34%
was China Business).
During the year ended March of 2016, sales at
Rohto Pharmaceutical Co., Ltd. were ¥167.02 billion (US$1.50 billion).
increase of 10.0%
versus 2015, when the company's sales were ¥151.77 billion.
This was the fifth consecutive year of sales increases at Rohto Pharmaceutical Co., Ltd.
(and since 2011, sales have increased a total of 45%).
Sales of Operating Segment-Europe saw an increase
that was more than double the company's growth rate: sales were up
26.7% in 2016, from
¥6.32 billion to ¥8.01 billion.
Rohto Pharmaceutical Co., Ltd. also saw significant increases in sales in
Operating Segment-Asia (up 13.2% to ¥51.62 billion)